Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002468956 | SCV002765639 | pathogenic | not provided | 2022-06-13 | criteria provided, single submitter | clinical testing | Reported in a patient with multiple osteochondromas in published literature (Raskind et al., 1998); however, clinical data is limited; Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 10679937, 9521425) |
Neuberg Centre For Genomic Medicine, |
RCV000002605 | SCV005060877 | likely pathogenic | Exostoses, multiple, type 1 | criteria provided, single submitter | clinical testing | The stop gained c.357C>A (p.Tyr119Ter) variant in the EXT1 gene has been reported previously in a patient with multiple osteochondromas (Raskind et al., 1998). This variant is absent in the gnomAD Exomes. It is submitted to ClinVar as Pathogenic. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Loss of function variants have been previously reported to be disease causing. The nucleotide change c.357C>A in EXT1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. Evidence in multiple individuals and additional studies are required to prove the pathogenicity of the variant. For these reasons, this variant has been classified as Likely Pathogenic. | |
OMIM | RCV000002605 | SCV000022763 | pathogenic | Exostoses, multiple, type 1 | 1998-01-01 | no assertion criteria provided | literature only |